Boehringer Ingelheim recently announced new positive data on the company’s FDA-approved therapy OFEV® (nintedanib) for the treatment of idiopathic pulmonary fibrosis (IPF). The results were presented at the Pulmonary Fibrosis Foundation’s PFF Summit 2015 in Washington, D.C. OFEV is a tyrosine-kinase inhibitor (TKI) that targets growth factors, such as the vascular endothelial…
Boehringer Ingelheim’s OFEV (Nintedanib) IPF Therapy Reinforces Efficacy and Safety Profile in New Studies
“Dot Delarosa always had a challenging life, but things got worse when she found out that she had Pulmonary Fibrosis. She needed a lung transplant immediately, or she would die. This is her story.” Learn more Pulmonary Fibrosis:Â https://bit.ly/1lfMsiZ…
The nonprofit phaware global association (phaware), an organization focused on raising awareness of pulmonary hypertension, has developed a new mobile app (phaware365) to help achieve its goal globally through an innovative and engaging strategy. Pulmonary hypertension (PH) is a life-threatening cardiopulmonary disorder characterized by an abnormally high blood pressure in the…
Singer-songwriter Mary Barry posted on Facebook that she’s been suffering for almost two years with Pulmonary Fibrosis. The Canadian singer felt it was about time to open up to her friends, family and fans about the deadly disease she has been struggling with. On her Facebook post she says: “Inspired by the…
Genentech, a member of the Roche Group, recently presented two abstracts on the company’s product Esbriet (pirfenidone), an oral drug developed for the treatment of pulmonary fibrosis (PF), at the American College of Chest Physicians Annual Meeting (CHEST 2015), held Oct. 24–28 in Montreal, Canada. Both abstracts were…
Esbriet (pirfenidone, Genentech) is an anti-fibrotic drug developed as a therapy for pulmonary fibrosis (PF), and was one of the first two drugs to receive approval for PF treatment in the United States. New data on Esbriet was recently presented by Dr. Steven Nathan, Medical Director, Advanced Lung Disease…
Learn more about Idiopathic Pulmonary Fibrosis:Â https://bit.ly/1QiRmr3…
Clinical trials are well-designed studies that collect information about new treatments for diseases and disorders. Most of the time, this means medications but clinical trials can also test other things such as stem cell therapies, surgical techniques, tests for diagnosis, medical devices and others. In particular, clinical trials focus on…
The Pulmonary Fibrosis Foundation (PFF) recently announced that the number of scientific poster presentations on idiopathic pulmonary fibrosis (IPF) and interstitial lung diseases (ILD) to be displayed at the upcoming PFF Summit 2015: From Bench to Bedside in Washington, D.C., reached a record. The PFF Summit 2015: From…
Help raise awareness for this serious and devastating disease. Learn more about Pulmonary Fibrosis:Â https://bit.ly/1lfMsiZ…
